ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2024, Vol. 33 ›› Issue (2): 192-196.DOI: 10.3969/j.issn.1006-298X.2024.02.018

• 临床集锦 • 上一篇    

新型冠状病毒感染诱发抗肾小球基膜肾炎及免疫性血小板减少

  

  • 出版日期:2024-04-28 发布日期:2024-04-23

COVID-19 infection induced anti-glomerular basement membrane nephritis with immune thrombocytopenia

  • Online:2024-04-28 Published:2024-04-23

摘要: 34岁女性患者,因“恶心、呕吐1月余,肉眼血尿伴血清肌酐(SCr)升高20余天”入院。患者入院前当地医院诊断新型冠状病毒感染、肠胃炎,随后出现肉眼血尿、尿量减少,伴贫血、血小板减少,SCr进行性升高需要行肾脏替代治疗,抗肾小球基膜(GBM)抗体阳性,血小板特异性抗体阳性,肾活检病理符合抗GBM肾炎。予抗感染、激素、利妥昔单抗、环磷酰胺及蛋白A免疫吸附治疗后患者病情好转脱离透析。


关键词: 新型冠状病毒, 抗肾小球基膜肾炎, 免疫性血小板减少

Abstract: This case reports one 34-year-old female patient who was admitted to the hospital with “nausea and vomiting for more than a month, gross hematuria with elevated serum creatinine for more than 20 days”. The patient was diagnosed with COVID-19 infection and gastroenteritis in the local hospital prior to admission. Subsequently,the patient developed gross hematuria, decreased urine output with anemia, thrombocytopenia, progressive elevation of serum creatinine requiring renal replacement therapy, positive anti-glomerular basement membrane (GBM) antibody, and positive platelet-specific antibodies. Renal biopsy was anti-GBM nephritis. After being given anti-infective drugs, glucocorticoids, rituximab, cyclophosphamide and protein A immunoadsorption therapy, the patient's condition improved and she withdrew from dialysis.


Key words: COVID-19, anti-glomerular basement membrane nephritis, immune thrombocytopenia